A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy

NCT00119600 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen